INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 146 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $2,057,131 | -90.5% | 166,300 | -89.3% | 0.01% | -92.0% |
Q3 2022 | $21,751,000 | +1137.3% | 1,559,183 | +1124.8% | 0.09% | +1142.9% |
Q2 2022 | $1,758,000 | +41.2% | 127,300 | +66.4% | 0.01% | +40.0% |
Q1 2022 | $1,245,000 | -85.1% | 76,500 | -85.1% | 0.01% | -84.8% |
Q4 2021 | $8,376,000 | -19.3% | 514,200 | -26.4% | 0.03% | -28.3% |
Q3 2021 | $10,376,000 | -85.7% | 698,700 | +7.8% | 0.05% | -86.0% |
Q1 2019 | $72,516,000 | +655.8% | 648,278 | +581.0% | 0.33% | +615.2% |
Q4 2018 | $9,595,000 | +1360.4% | 95,200 | +1730.8% | 0.05% | +1433.3% |
Q3 2018 | $657,000 | -96.2% | 5,200 | -98.2% | 0.00% | -95.8% |
Q1 2018 | $17,342,000 | +979.2% | 281,900 | +925.1% | 0.07% | +928.6% |
Q4 2017 | $1,607,000 | -51.8% | 27,500 | -52.2% | 0.01% | -53.3% |
Q3 2017 | $3,337,000 | -90.3% | 57,500 | -79.9% | 0.02% | -92.3% |
Q2 2017 | $34,578,000 | +38.6% | 285,600 | +29.5% | 0.19% | +39.6% |
Q1 2017 | $24,950,000 | +17.7% | 220,600 | +13.1% | 0.14% | -6.1% |
Q4 2016 | $21,198,000 | +1502.3% | 195,100 | +1794.2% | 0.15% | +1380.0% |
Q1 2016 | $1,323,000 | -96.5% | 10,300 | -92.2% | 0.01% | -96.1% |
Q1 2015 | $37,311,000 | -20.3% | 132,300 | -55.9% | 0.25% | -22.8% |
Q4 2014 | $46,831,000 | +430.4% | 300,200 | +704.8% | 0.33% | +398.5% |
Q3 2014 | $8,829,000 | +40.8% | 37,300 | +40.8% | 0.07% | +65.0% |
Q2 2014 | $6,271,000 | – | 26,500 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 640,688 | $9,514,000 | 1.49% |
CM Management, LLC | 45,000 | $668,000 | 0.50% |
EULAV Asset Management | 660,000 | $9,801,000 | 0.26% |
DLD Asset Management, LP | 225,200 | $3,346,000 | 0.24% |
Virtus ETF Advisers LLC | 21,387 | $318,000 | 0.14% |
GSA CAPITAL PARTNERS LLP | 79,145 | $1,175,000 | 0.12% |
Hennion & Walsh Asset Management, Inc. | 136,720 | $2,030,000 | 0.11% |
ALTRINSIC GLOBAL ADVISORS LLC | 168,800 | $2,507,000 | 0.08% |
Inspire Investing, LLC | 31,868 | $473,000 | 0.06% |
DUALITY ADVISERS, LP | 51,196 | $760,000 | 0.06% |